ID
37162
Description
Study ID: 104864/502 Clinical Study ID: 104864/502 Study Title: An Open-Label, Multicenter, Randomized, Phase II Study of Oral Topotecan Daily x 5 Days vs. Oral Topotecan 5 Days On, 2 Days Off for 3 Weeks for Second-Line Treatment in Patients with Recurrent, Locally Advanced or Metastatic Cervical Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: N/A Study Indication: Cancer, Locally Advanced or Metastatic Cervical Cancer
Keywords
Versions (1)
- 7/5/19 7/5/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
July 5, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Oral Topotecan Daily x 5 Days vs. Oral Topotacan 5 Days On, 2 Days Off; 104864/502
Study Medication Daily X5 Days Regimen
- StudyEvent: ODM
Description
Weight/Body Surface Area
Alias
- UMLS CUI-1
- C0005910
- UMLS CUI-2
- C0005902
Description
Body Weight, Unit of measure
Data type
text
Alias
- UMLS CUI [1,1]
- C0005910
- UMLS CUI [1,2]
- C1519795
Description
Body Weight
Data type
float
Alias
- UMLS CUI [1]
- C0005910
Description
Body Surface Area
Data type
float
Measurement units
- m2
Alias
- UMLS CUI [1]
- C0005902
Description
Oral Topotecan Study Medication Record - Daily X5 Days Regime - Days 1-5
Alias
- UMLS CUI-1
- C0146224
- UMLS CUI-2
- C0392920
Description
Topotecan, Chemotherapy Regimen, Start Date
Data type
date
Alias
- UMLS CUI [1,1]
- C0146224
- UMLS CUI [1,2]
- C0392920
- UMLS CUI [1,3]
- C0808070
Description
Topotecan, Chemotherapy Regimen, End Date
Data type
date
Alias
- UMLS CUI [1,1]
- C0146224
- UMLS CUI [1,2]
- C0392920
- UMLS CUI [1,3]
- C0806020
Description
Topotecan, Chemotherapy Regimen, Daily Dose, Scheduled
Data type
float
Measurement units
- mg/m2
Alias
- UMLS CUI [1,1]
- C0146224
- UMLS CUI [1,2]
- C0392920
- UMLS CUI [1,3]
- C2348070
- UMLS CUI [1,4]
- C0205539
Description
Topotecan, Chemotherapy Regimen, Daily Dose, Actual
Data type
float
Measurement units
- mg/m2
Alias
- UMLS CUI [1,1]
- C0146224
- UMLS CUI [1,2]
- C0392920
- UMLS CUI [1,3]
- C2348070
- UMLS CUI [1,4]
- C0237400
Description
Topotecan, Chemotherapy Regimen, Dose Reduced
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0146224
- UMLS CUI [1,2]
- C0392920
- UMLS CUI [1,3]
- C1707814
Description
Topotecan, Chemotherapy Regimen, Dose Reduced, Indication
Data type
text
Alias
- UMLS CUI [1,1]
- C0146224
- UMLS CUI [1,2]
- C0392920
- UMLS CUI [1,3]
- C1707814
- UMLS CUI [1,4]
- C0392360
Description
Topotecan, Chemotherapy Regimen, Dose Reduced, Indication
Data type
text
Alias
- UMLS CUI [1,1]
- C0146224
- UMLS CUI [1,2]
- C0392920
- UMLS CUI [1,3]
- C1707814
- UMLS CUI [1,4]
- C0392360
Similar models
Study Medication Daily X5 Days Regimen
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0005902 (UMLS CUI-2)
C1519795 (UMLS CUI [1,2])
C0392920 (UMLS CUI-2)
C0392920 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,2])
C2348070 (UMLS CUI [1,3])
C0205539 (UMLS CUI [1,4])
C0392920 (UMLS CUI [1,2])
C2348070 (UMLS CUI [1,3])
C0237400 (UMLS CUI [1,4])
C0392920 (UMLS CUI [1,2])
C1707814 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,2])
C1707814 (UMLS CUI [1,3])
C0392360 (UMLS CUI [1,4])
C0392920 (UMLS CUI [1,2])
C1707814 (UMLS CUI [1,3])
C0392360 (UMLS CUI [1,4])
No comments